Northern General Hospital

The trials here

What the 19 trials at this site are about, from their registry records.

Conditions

• Heart failure5 trials
• Atrial fibrillation2 trials
• Bronchiectasis2 trials
• IgA nephropathy2 trials
• Polycystic kidney disease2 trials
• Type 2 diabetes2 trials
• Aortic stenosis1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Osteoarthritis1 trial
• Stroke1 trial
• and 1 more

Phase

• Phase 38 trials
• Phase 23 trials

Status

• Recruiting8 trials
• Active, not recruiting7 trials
• Completed2 trials
• Not yet recruiting2 trials

Lead sponsor

• Boehringer Ingelheim4 trials
• AtriCure, Inc.2 trials
• Vertex Pharmaceuticals Incorporated2 trials
• Abbott Diabetes Care1 trial
• Biogen1 trial
• and 9 more

Running trials

• Not yet recruiting

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

  NCT07161037· Phase 2· Vertex Pharmaceuticals Incorporated· Source

• Recruiting

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· Phase 3· Takeda· Source

  Contact: Arif Khwaja (principal investigator)

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

  NCT06991257· Phase 2· Pfizer· Source

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· Phase 3· Biogen· Source

  Contact: Salim Arif Khwaja (principal investigator)

• Recruiting

  Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

  NCT06435156· Phase 2· University of Dundee· Source

  Contact: Ify Mordi, MBChB, MD

• Active, not recruiting

  Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

  NCT06747572· Vertex Pharmaceuticals Incorporated· Source

• Recruiting

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  NCT06424288· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  CGM Use in Adults With Type 2 Diabetes on Basal Insulin

  NCT05944432· Abbott Diabetes Care· Source

• Recruiting

  RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

  NCT05568069· University Hospital Southampton NHS Foundation Trust· Source

  Contact: Dominic Rogers, Dr

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

  NCT05478304· AtriCure, Inc.· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  iCorMicA - Stratified Medicine in Angina

  NCT04674449· NHS Greater Glasgow and Clyde· Source

  Contact: Paul Morris

• Recruiting

  The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

  NCT04204915· University of Leicester· Source

  Contact: Dr Muhhammad Aetesam-ur-Rahman

• Active, not recruiting

  Total Ankle Replacement Versus Arthrodesis Trial

  NCT02128555· University College, London· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure5 recruiting
• Bronchiectasis2 recruiting
• IgA nephropathy2 recruiting
• Aortic stenosis1 recruiting
• Coronary artery disease1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source

• Completed

  Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation

  NCT02695277· AtriCure, Inc.· Source